Calavo Growers to Report Second Quarter 2020 Financial Results on June 8, 2020
SANTA PAULA, Calif., May 19, 2020 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado-industry leader and provider […]
URBN Reports Preliminary Q1 Results
PHILADELPHIA, May 19, 2020 (GLOBE NEWSWIRE) — Urban Outfitters, Inc. (NASDAQ:URBN), a leading lifestyle products and services company which operates […]
Performant Financial Corporation Announces Financial Results for First Quarter 2020
LIVERMORE, Calif., May 19, 2020 (GLOBE NEWSWIRE) — Performant Financial Corporation (Nasdaq: PFMT), (the “Company”), a leading provider of technology-enabled […]
Kornit Digital Reports First Quarter 2020 Results
First quarter revenue of $26.2 million, net of non-cash warrants impact of $0.6 millionFirst quarter 2020 GAAP operating loss of […]
Xcel Brands, Inc. Announces First Quarter 2020 Results
• First Quarter Total Revenues of $9.5 Million, • GAAP Net Loss of $0.8 million, Diluted EPS of ($0.04) and • non-GAAP […]
Assembly Biosciences Announces Move to Virtual-Only Annual Meeting of Stockholders on June 11, 2020
SOUTH SAN FRANCISCO, Calif., May 19, 2020 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB) today announced that it will […]
CNB Financial Announces Second Quarter Dividend
CLEARFIELD, Penn., May 19, 2020 (GLOBE NEWSWIRE) — The Board of Directors of CNB Financial Corporation [Nasdaq: CCNE] has announced […]
IntriCon Acquires Emerald Medical Services
Synergistic joint development and manufacturing capability expands market opportunity in surgical navigationProvides immediate access to technology platform serving new high […]
Ascendis Pharma A/S Reports First Quarter 2020 Financial Results
– On track for filing U.S. Biologics License Application for TransCon hGH in second quarter, and advancing Marketing Authorisation Application […]
Cue Biopharma Reports First Quarter 2020 Results, Updates of CUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights
CAMBRIDGE, Mass., May 19, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel […]
